TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR)
- Status
- UNKNOWN
- Phase
- PHASE4
Clinical Trials Related to Tenofovir Alafenamide
Related studies linked through entity extraction aliases.
Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
TAF Real World Study for Universal Effectiveness
- Status
- UNKNOWN
- Phase
- N/A
Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus
- Status
- UNKNOWN
- Phase
- PHASE4
Assessing Virologic Success and Metabolic Changes in Patients Switching From a TDF to TAF Containing Antiretroviral Therapy Regimen
- Status
- COMPLETED
- Phase
- N/A
The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure
- Status
- UNKNOWN
- Phase
- N/A
Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver
- Status
- UNKNOWN
- Phase
- PHASE4
Treatment Efficacy and Safety of TDF-TAF Switch Study in South Korea
- Status
- UNKNOWN
- Phase
- N/A
Impact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers (YODA)
- Status
- COMPLETED
- Phase
- PHASE1
Entecavir to TAF Switch
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Treatment Outcomes in Chronic Hepatitis B Patients on Sequential Therapy With Tenofovir Alafenamide (TAF)
- Status
- COMPLETED
- Phase
- PHASE4
Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir.
- Status
- COMPLETED
- Phase
- PHASE4
ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy
- Status
- COMPLETED
- Phase
- PHASE3
TAF for HIV-HBV With Renal Dysfunction
- Status
- COMPLETED
- Phase
- PHASE2
The HOPE Study: Characterizing Patients With Hepatitis B and C
- Status
- RECRUITING
- Phase
- N/A
Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide
- Status
- UNKNOWN
- Phase
- PHASE4
PK and PD Study of Oral F/TAF for HIV Prevention
- Status
- COMPLETED
- Phase
- PHASE1
A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2